These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 23928239
21. Standardized diagnosis and reporting of breast cancer. Thomassin-Naggara I, Tardivon A, Chopier J. Diagn Interv Imaging; 2014; 95(7-8):759-66. PubMed ID: 25017150 [Abstract] [Full Text] [Related]
24. Breast Imaging Reporting and Data System category 3 for magnetic resonance imaging. Lee KA. Top Magn Reson Imaging; 2014 Dec; 23(6):337-44. PubMed ID: 25463408 [Abstract] [Full Text] [Related]
26. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ. Tozaki M. Breast Cancer; 2013 Jan; 20(1):13-20. PubMed ID: 22109641 [Abstract] [Full Text] [Related]
30. Breast MR Imaging: Atlas of Anatomy, Physiology, Pathophysiology, and Breast Imaging Reporting and Data Systems Lexicon. Martaindale SR. Magn Reson Imaging Clin N Am; 2018 May; 26(2):179-190. PubMed ID: 29622124 [Abstract] [Full Text] [Related]
31. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Vassiou K, Kanavou T, Vlychou M, Poultsidi A, Athanasiou E, Arvanitis DL, Fezoulidis IV. Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425 [Abstract] [Full Text] [Related]
33. Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH. Cancer; 2009 Apr 01; 115(7):1363-80. PubMed ID: 19197974 [Abstract] [Full Text] [Related]
34. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound. Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, Pronio A, Kirchin MA, Passariello R. Invest Radiol; 2009 Jul 01; 44(7):412-21. PubMed ID: 19448554 [Abstract] [Full Text] [Related]
36. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA. AJR Am J Roentgenol; 2010 Jun 01; 194(6):1658-63. PubMed ID: 20489110 [Abstract] [Full Text] [Related]
37. MR imaging in probably benign lesions (BI-RADS category 3) of the breast. Gökalp G, Topal U. Eur J Radiol; 2006 Mar 01; 57(3):436-44. PubMed ID: 16316732 [Abstract] [Full Text] [Related]
38. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category. Seely JM, Nguyen ET, Jaffey J. Acta Radiol; 2007 Oct 01; 48(8):838-45. PubMed ID: 17851971 [Abstract] [Full Text] [Related]
39. Breast cancer: prediction with artificial neural network based on BI-RADS standardized lexicon. Baker JA, Kornguth PJ, Lo JY, Williford ME, Floyd CE. Radiology; 1995 Sep 01; 196(3):817-22. PubMed ID: 7644649 [Abstract] [Full Text] [Related]
40. Who should have breast magnetic resonance imaging evaluation? Orel S. J Clin Oncol; 2008 Feb 10; 26(5):703-11. PubMed ID: 18258977 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]